Abnormal polybrene-induced platelet agglutination in von Willebrand's disease

Monitoring unfractionated heparin therapy with antifactor Xa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time.

Pharmacotherapy·1999

In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone.

Pharmacotherapy·1998

Comparing different lots of activated partial thromboplastin time reagent: analysis of two methods.

American journal of clinical pathology·1998

Differences in the metabolism of postprandial lipoproteins after a high-monounsaturated-fat versus a high-carbohydrate diet in patients with type 1 diabetes mellitus.

Arteriosclerosis, thrombosis, and vascular biology·1998

Diagnosis and outcome of 100 consecutive patients with extreme granulocytic leukocytosis.

The American journal of medicine·1998

Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients.

American journal of clinical pathology·1997

Clinical and molecular characteristics of hereditary factor XII deficiency in Chinese Han patients: Novel mutations, a high-frequency frameshift variant, and plasma metabolomic profiling.

Thrombosis research·2026

Distinct coagulation-fibrinolysis profiles in traumatic and upper gastrointestinal hemorrhagic shock: Clinical relevance of tPA/PAI-1 complex in traumatic hemorrhagic shock.

Thrombosis research·2026

Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy.

Thrombosis research·2026

Development and external validation of a text-matching algorithm to identify patients with lower extremity deep venous thrombosis from radiology reports at five medical centers.

Thrombosis research·2026

Predicting chronic immune thrombocytopenia in children using IFNA17 rs9298814 polymorphism and clinical features: a study from a low- and middle-income country.

Thrombosis research·2026

Long-term analytical performance of apixaban measurements based on external quality assessment data.

Thrombosis research·2026

Development and initial clinical application of the HKL Thrombus Burden Classification for endovascular salvage of thrombosed haemodialysis access.

The journal of vascular access·2026

Clonal hematopoiesis in immune-related and neurological disorders.

Immunological medicine·2026

Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).

British journal of haematology·2026

Recurrent Postpartum Atypical Hemolytic Uremic Syndrome Caused by a C3 Pathogenic Variant: A Case Report.

International journal of women's health·2026

Point-of-care assessment of complement activation in the ICU: a feasibility study of rapid terminal complement complex detection in critical illness.

Frontiers in immunology·2026

Utility of TcPO2 in Assessing Microcirculatory Improvement and Minimizing Amputation Levels for Hemodialysis Access-Induced Distal Ischemia: A Case Report.

Yonago acta medica·2026

Related Experiment Videos

Abnormal polybrene-induced platelet agglutination in von Willebrand's disease

Related Concept Videos

Monitoring unfractionated heparin therapy with antifactor Xa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time.

In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone.

Comparing different lots of activated partial thromboplastin time reagent: analysis of two methods.

Differences in the metabolism of postprandial lipoproteins after a high-monounsaturated-fat versus a high-carbohydrate diet in patients with type 1 diabetes mellitus.

Diagnosis and outcome of 100 consecutive patients with extreme granulocytic leukocytosis.

Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients.

Clinical and molecular characteristics of hereditary factor XII deficiency in Chinese Han patients: Novel mutations, a high-frequency frameshift variant, and plasma metabolomic profiling.

Distinct coagulation-fibrinolysis profiles in traumatic and upper gastrointestinal hemorrhagic shock: Clinical relevance of tPA/PAI-1 complex in traumatic hemorrhagic shock.

Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy.

Development and external validation of a text-matching algorithm to identify patients with lower extremity deep venous thrombosis from radiology reports at five medical centers.

Predicting chronic immune thrombocytopenia in children using IFNA17 rs9298814 polymorphism and clinical features: a study from a low- and middle-income country.

Long-term analytical performance of apixaban measurements based on external quality assessment data.

Development and initial clinical application of the HKL Thrombus Burden Classification for endovascular salvage of thrombosed haemodialysis access.

Clonal hematopoiesis in immune-related and neurological disorders.

Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).

Recurrent Postpartum Atypical Hemolytic Uremic Syndrome Caused by a C3 Pathogenic Variant: A Case Report.

Point-of-care assessment of complement activation in the ICU: a feasibility study of rapid terminal complement complex detection in critical illness.

Utility of TcPO2 in Assessing Microcirculatory Improvement and Minimizing Amputation Levels for Hemodialysis Access-Induced Distal Ischemia: A Case Report.

Related Experiment Videos

Abnormal polybrene-induced platelet agglutination in von Willebrand's disease

Related Concept Videos

Related Articles